then there doesn’t seem to be much merit in burning costs for a partial RC110 trial then transition to RC220, unless I have missed something. If we take this view then how can RC220 be used in an AML trial before 2025 whilst keeping shareholders happy?
It’s a tough one, delivery of RC220 might be be a huge relief but market is dying for a solution. Hopefully Race can deliver and hasn’t shot themselves in the foot with ‘swiftly’ and using ‘current resources’.
The delay of the strategy is intriguing if it hits the mark, or just buying time for the inevitable?
p.s. a few ppl was grass is greener-itis, even though results have been onpoint!
Ann: RC220 Meets Quality Specifications, page-76
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |